| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia
|
Babakhanlou, Rodrick
|
|
|
102 |
12 |
p. 3427-3430
|
article
|
| 2 |
A case report of dyskeratosis congenita caused by a novel TERC mutation
|
Liang, Weiru
|
|
|
102 |
12 |
p. 3629-3630
|
article
|
| 3 |
An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis
|
Xu, Ying
|
|
|
102 |
12 |
p. 3325-3333
|
article
|
| 4 |
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study
|
Lai, Hurong
|
|
|
102 |
12 |
p. 3413-3426
|
article
|
| 5 |
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015
|
Liu, Kangkang
|
|
|
102 |
12 |
p. 3431-3444
|
article
|
| 6 |
Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type
|
Xu, Tianzi
|
|
|
102 |
12 |
p. 3521-3532
|
article
|
| 7 |
Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome
|
Treiber, Hannes
|
|
|
102 |
12 |
p. 3631-3633
|
article
|
| 8 |
Clonal myeloid disorders following CAR T-cell therapy
|
Andersen, Michael
|
|
|
102 |
12 |
p. 3643-3645
|
article
|
| 9 |
c-Myc inhibits LAPTM5 expression in B-cell lymphomas
|
Zhang, Yanqing
|
|
|
102 |
12 |
p. 3499-3513
|
article
|
| 10 |
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China
|
Li, Xiaosheng
|
|
|
102 |
12 |
p. 3465-3475
|
article
|
| 11 |
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
|
Kriege, Oliver
|
|
|
102 |
12 |
p. 3635-3637
|
article
|
| 12 |
Discovering a novel pathogenic CDAN1 variant using exome sequencing and bioinformatics analysis
|
Cai, Ling-Hu
|
|
|
102 |
12 |
p. 3621-3623
|
article
|
| 13 |
Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors
|
Cao, Junjie
|
|
|
102 |
12 |
p. 3567-3573
|
article
|
| 14 |
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms
|
Zheng, Xinhui
|
|
|
102 |
12 |
p. 3603-3611
|
article
|
| 15 |
E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia
|
Liu, Yanfeng
|
|
|
102 |
12 |
p. 3345-3355
|
article
|
| 16 |
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
|
Thanhakun, Ronakrit
|
|
|
102 |
12 |
p. 3533-3541
|
article
|
| 17 |
Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
|
Hu, Jiajia
|
|
|
102 |
12 |
p. 3593-3601
|
article
|
| 18 |
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
|
McBride, Helen J.
|
|
|
102 |
12 |
p. 3299-3309
|
article
|
| 19 |
Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy
|
Tang, Hongwei
|
|
|
102 |
12 |
p. 3401-3412
|
article
|
| 20 |
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
|
Visentini, Marcella
|
|
|
102 |
12 |
p. 3457-3463
|
article
|
| 21 |
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
|
Weng, Guangyang
|
|
|
102 |
12 |
p. 3369-3381
|
article
|
| 22 |
Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report
|
Li, Changyou
|
|
|
102 |
12 |
p. 3625-3627
|
article
|
| 23 |
IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy
|
Wang, Xindi
|
|
|
102 |
12 |
p. 3575-3585
|
article
|
| 24 |
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
|
Kovacsova, Flora
|
|
|
102 |
12 |
p. 3587-3591
|
article
|
| 25 |
Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis
|
Koike, Takashi
|
|
|
102 |
12 |
p. 3311-3323
|
article
|
| 26 |
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia
|
Li, Huibo
|
|
|
102 |
12 |
p. 3357-3367
|
article
|
| 27 |
Multiple myeloma relapse as extramedullary plasmacytoma of the penis
|
Coelho, Henrique
|
|
|
102 |
12 |
p. 3649-3651
|
article
|
| 28 |
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
|
Johansson, Patricia
|
|
|
102 |
12 |
p. 3445-3455
|
article
|
| 29 |
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system
|
Shawahna, Ramzi
|
|
|
102 |
12 |
p. 3543-3554
|
article
|
| 30 |
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
|
Ebid, Osama Abd El Hameed
|
|
|
102 |
12 |
p. 3477-3488
|
article
|
| 31 |
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
|
Koschmieder, Steffen
|
|
|
102 |
12 |
p. 3383-3399
|
article
|
| 32 |
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies
|
Kikuchi, Taku
|
|
|
102 |
12 |
p. 3489-3497
|
article
|
| 33 |
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians
|
Dieterle, Martin Philipp
|
|
|
102 |
12 |
p. 3639-3641
|
article
|
| 34 |
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
|
Wang, Shufen
|
|
|
102 |
12 |
p. 3555-3566
|
article
|
| 35 |
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
|
Dai, Jia‑wen
|
|
|
102 |
12 |
p. 3335-3343
|
article
|
| 36 |
The experience of diagnosis and treatment for TAFRO syndrome
|
Wu, Xiaolong
|
|
|
102 |
12 |
p. 3515-3520
|
article
|
| 37 |
The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia
|
Candan, Ozlem
|
|
|
102 |
12 |
p. 3647-3648
|
article
|
| 38 |
Validation of venous thromboembolism predictive model in hematologic malignancies
|
López Sacerio, Agnerys
|
|
|
102 |
12 |
p. 3613-3620
|
article
|
Journal description